FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Steuber

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Prostate

Co-author Network

Publications

TOP 3
Lia Burkhardt; Sarah Fuchs; Markus Graefen; Hartwig Huland; Martina Kluth; Antje Krohn; Malte Mader; Sawinee Masser; Sarah Minner; Guido Sauter; Thorsten Schlomm; Hüseyin Sirma; Thomas Steuber; Frederik Bachmann; Ronald Simon
CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer.
Julia Müller; Guido Sauter; Thorsten Schlomm; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Lia Burkhardt; Arne Ehlers; Markus Graefen; Sarah Minner; Uwe Michl
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.
Olaf J C Hellwinkel; Hendrik Isbarn; Thorsten Schlomm; Christina Sellier; Thomas Steuber; Holger Sültmann; Yu-Mi Jessica Sylvester; Jan C Brase; Andreas Erbersdobler; Christina Wagner
A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Steuber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lia Burkhardt; Sarah Fuchs; Markus Graefen; Hartwig Huland; Martina Kluth; Antje Krohn; Malte Mader; Sawinee Masser; Sarah Minner; Guido Sauter; Thorsten Schlomm; Hüseyin Sirma; Thomas Steuber; Frederik Bachmann; Ronald Simon
CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer.
Cancer research 2013;73(9):2795-805.
2013: Julia Müller; Guido Sauter; Thorsten Schlomm; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Lia Burkhardt; Arne Ehlers; Markus Graefen; Sarah Minner; Uwe Michl
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.
International journal of cancer. Journal international du cancer 2013;132(6):1333-40.
2013: Olaf J C Hellwinkel; Hendrik Isbarn; Thorsten Schlomm; Christina Sellier; Thomas Steuber; Holger Sültmann; Yu-Mi Jessica Sylvester; Jan C Brase; Andreas Erbersdobler; Christina Wagner
A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue.
International journal of molecular sciences 2013;14(3):5239-49.
2013: Georg Salomon; Mareike Sandmann; Thorsten Schlomm; Jan Spethmann; Philippe Autier; Ann Beckmann; Leopold Durner; Markus Graefen; Alexander Haese; Hans Heinzer; Uwe Michl; Caroline Moore; Thomas Steuber
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomy.
BJU international 2013;111(1):60-6.
2013: Jens Hansen; Pierre I Karakiewicz; Luis A Kluth; Michael Rink; Shahrokh F Shariat; Thomas Steuber; Zhe Tian; Sascha A Ahyai; Marco Bianchi; Alberto Briganti; Margit Fisch; Markus Graefen; Felix K-H Chun
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
The Prostate 2013;73(2):211-8.
2012: Lars Budäus; Felix K-H Chun; Margit Fisch; Alexander Haese; Hans Heinzer; Hartwig Huland; Hendrik Isbarn; Uwe Michl; Georg Salomon; Thorsten Schlomm; Thomas Steuber; Pierre Tennstedt; Markus Graefen
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
BJU international 2012;110(11):1714-20.
2012: J Schmitges; Q-D Trinh; L Budäus; Markus Graefen; Hans Heinzer; Hartwig Huland; L Jonas; Pierre I Karakiewicz; R Larbig; Thorsten Schlomm; Thomas Steuber
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(11):1082-8.
2012: Jens Hansen; Hans Heinzer; Hartwig Huland; Michael Rink; Georg Salomon; Thorsten Schlomm; Jan Spethmann; Thomas Steuber; Lars Budäus; Markus Graefen; Alexander Haese; Uwe Michl
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy.
Urology 2012;80(4):877-82.
2012: Antje Krohn; Stefan Kurtz; Malte Mader; Pascale-Sophie Mayer; Marie Meyer-Kornblum; Sarah Minner; Christoph Plass; Fred Saad; Guido Sauter; Lia Burkhardt; Colin De Silva; Tobias Diedler; Clarissa Gerhäuser; Markus Graefen; Joseph Huang; Darja Kötschau; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Pierre Tennstedt; Thorsten Schlomm
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.
The American journal of pathology 2012;181(2):401-12.
2012: Thorsten Schlomm; Thomas Steuber; Stefan Steurer; Pierre Tennstedt; Corinna Wittmer; Lars Budäus; Markus Graefen; Alexander Haese; Jens Hansen; Hans Heinzer; Caroline Huxhold; Uwe Michl; Sarah Minner; Georg Salomon; Guido Sauter; Hartwig Huland
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.
European urology 2012;62(2):333-40.
2012: J Schmitges; M Sun; Q-D Trinh; F Abdollah; M Bianchi; L Budäus; F K Chun; Markus Graefen; H Isbarn; Pierre I Karakiewicz; Thorsten Schlomm; Thomas Steuber
Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(7):624-9.
2012: Jan Schmitges; Shahrokh F Shariat; Thomas Steuber; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Sascha A Ahyai; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
International urology and nephrology 2012;44(3):799-806.
2012: Pierre Tennstedt; Thomas Steuber; Andreas Brüchmann; Markus Graefen; Alexander Haese; Hartwig Huland; Patricia Köster; Sarah Minner; Martina Mirlacher; Guido Sauter; Thorsten Schlomm; Ronald Simon
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
International journal of oncology 2012;40(1):261-8.
2011: Lars Budäus; Margit Fisch; Markus Graefen; Alexander Haese; Hans Heinzer; Hartwig Huland; Hendrik Isbarn; Georg Salomon; Thorsten Schlomm; Jan Schmitges; Jan Spethmann; Laura Beesch; Thomas Steuber
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.
BJU international 2011;108(8):1256-61.
2011: Sarah Minner; Julia Müller; Klaus Pantel; Guido Sauter; Hartmut Schlüter; Laura Scholz; Udo Schumacher; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Pierre Tennstedt; Carsten Bokemeyer; Jan C Brase; Malaika Enodien; Markus Graefen; Antje Krohn; Alvin Y Liu; Andreas M Luebke; Pascale S Mayer; Thorsten Schlomm
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(18):5878-88.
2011: Thorsten Schlomm; Thomas Steuber; Uwe Michl; Georg Salomon; Oliver Engel; Markus Graefen; Alexander Haese; Hans Heinzer; Hartwig Huland
Full functional-length urethral sphincter preservation during radical prostatectomy.
European urology 2011;60(2):320-9.
2011: Thomas Steuber; Lars Budäus; Jochen Walz; Kevin C Zorn; Thorsten Schlomm; fianceeyi chun; Sascha A Ahyai; Margit Fisch; Guido Sauter; Hartwig Huland; Markus Graefen; Alexander Haese
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
BJU international 2011;107(11):1755-61.
2011: Sarah Minner; Corinna Wittmer; Markus Graefen; Georg Salomon; Thomas Steuber; Alexander Haese; Hartwig Huland; Carsten Bokemeyer; Emre F Yekebas; Judith Dierlamm; Stefan Balabanov; Ergin Kilic; Waldemar Wilczak; Ronald Simon; Guido Sauter; Thorsten Schlomm
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
The Prostate 2011;71(3):281-8.
2010: Sascha A Ahyai; Mario Zacharias; Hendrik Isbarn; Thomas Steuber; Christian Eichelberg; Jens Köllermann; Margit Fisch; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen; fianceeyi chun
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
BJU international 2010;106(4):478-83.
2010: Hendrik Isbarn; Manuela Wanner; Georg Salomon; Thomas Steuber; Thorsten Schlomm; Jens Köllermann; Guido Sauter; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
BJU international 2010;106(1):37-43.
2010: Giovanni Lughezzani; Lars Budäus; Hendrik Isbarn; Maxine Sun; Paul Perrotte; Alexander Haese; fianceeyi chun; Thorsten Schlomm; Thomas Steuber; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
European urology 2010;57(4):562-8.
2010: Sarah Minner; Birte Jessen; Lars Stiedenroth; Eike Burandt; Jens Köllermann; Martina Mirlacher; Andreas Erbersdobler; Christian Eichelberg; Margit Fisch; Tim H Brümmendorf; Carsten Bokemeyer; Ronald Simon; Thomas Steuber; Markus Graefen; Hartwig Huland; Guido Sauter; Thorsten Schlomm
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1553-60.
2010: Sascha A Ahyai; Hendrik Isbarn; Pierre I Karakiewicz; fianceeyi chun; Mathias Reichert; Jochen Walz; Thomas Steuber; Claudio Jeldres; Thorsten Schlomm; Hans Heinzer; Georg Salomon; Lars Budäus; Paul Perrotte; Hartwig Huland; Markus Graefen; Alexander Haese
The presence of prostate cancer on saturation biopsy can be accurately predicted.
BJU international 2010;105(5):636-41.
2010: Thomas Steuber; Thorsten Schlomm; H Heinzer; Mario Zacharias; S Ahyai; K F Chun; Alexander Haese; Susanne Klutmann; Jens Köllermann; G Sauter; Janos Mester; Pal Mikecz; M Fisch; Hartwig Huland; Markus Graefen; Georg Salomon
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
European journal of cancer (Oxford, England : 1990) 2010;46(2):449-55.
2009: Hans Heinzer; Thomas Steuber
Prostate cancer in the elderly.
Urologic oncology 2009;27(6):668-72.
2009: Hendrik Isbarn; Claudio Jeldres; Lars Budäus; Georg Salomon; Thorsten Schlomm; Thomas Steuber; fianceeyi chun; Sascha A Ahyai; Umberto Capitanio; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen; Pierre Karakiewicz
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
Urology 2009;73(3):615-9.
2009: fianceeyi chun; Nazareno Suardi; umberto capitanio; Claudio Jeldres; Sascha A Ahyai; Markus Graefen; Alexander Haese; Thomas Steuber; Andreas Erbersdobler; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):617-28-6.
2009: Georg Salomon; Hendrik Isbarn; Lars Budaeus; Thorsten Schlomm; Alberto Briganti; Thomas Steuber; Hans Heinzer; Alexander Haese; Markus Graefen; Pierre I Karakiewicz; Hartwig Huland; fianceeyi chun
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
The journal of sexual medicine 2009;6(2):498-504.
2009: N Bhojani; Sascha A Ahyai; Markus Graefen; umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):123-8.
2008: umberto capitanio; Sascha A Ahyai; Markus Graefen; Claudio Jeldres; Shahrokh F Shariat; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Paul Perrotte; François Péloquin; Daniel Pharand; Philippe Arjane; Hartwig Huland; Pierre I Karakiewicz
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: Jochen Walz; Alexander Haese; Vincenzo Scattoni; Thomas Steuber; Felix K-H Chun; Alberto Briganti; Francesco Montorsi; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
Cancer 2008;113(10):2695-703.
2008: Sascha A Ahyai; Markus Graefen; Thomas Steuber; Alexander Haese; Thorsten Schlomm; Jochen Walz; Jens Köllermann; Alberto Briganti; Mario Zacharias; Martin G Friedrich; Pierre I Karakiewicz; Francesco Montorsi; Hartwig Huland; Felix K-H Chun
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
European urology 2008;53(4):750-7.
2008: Thorsten Schlomm; Esther Näkel; Andreas Lübke; Andreas Buness; Felix K-H Chun; Thomas Steuber; Markus Graefen; Ronald Simon; Guido Sauter; Annemarie Poustka; Hartwig Huland; Andreas Erbersdobler; Holger Sültmann; Olaf J C Hellwinkel
Marked gene transcript level alterations occur early during radical prostatectomy.
European urology 2008;53(2):333-44.
2007: Thorsten Schlomm; Patrick Kirstein; Liv Iwers; Birte Daniel; Thomas Steuber; Jochen Walz; fianceeyi chun; Alexander Haese; Jens Kollermann; Markus Graefen; Hartwig Huland; Guido Sauter; Ronald Simon; Andreas Erbersdobler
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6579-84.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Francesco Montorsi; Christopher Porter; Vincenzo Scattoni; Andrea Gallina; Jochen Walz; Alexander Haese; Thomas Steuber; Andreas Erbersdobler; Thorsten Schlomm; Sascha A Ahyai; Eike Currlin; Luc Valiquette; Hans Heinzer; Patrizio Rigatti; Hartwig Huland; Pierre I Karakiewicz
Development and external validation of an extended 10-core biopsy nomogram.
European urology 2007;52(2):436-44.
2007: Martin G Friedrich; M I Toma; J K H F Chun; Thomas Steuber; L Budäus; H Isbarn; Hartwig Huland
[DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder].
Der Urologe. Ausg. A 2007;46(7):761-8.
2007: Thomas Steuber; Andrew J Vickers; Alexander Haese; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
2007: Felix K-H Chun; Alberto Briganti; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Thomas Steuber; Andrea Gallina; Jochen Walz; Paul Perrotte; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
European urology 2007;51(4):949-55; discussion 955.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Christopher Porter; Francesco Montorsi; Alexander Haese; Vincenzo Scattoni; Lester Borden; Thomas Steuber; Andrea Salonia; Thorsten Schlomm; Kalyan Latchemsetty; Jochen Walz; Jason Kim; Christian Eichelberg; Eike Currlin; Sascha A Ahyai; Andreas Erbersdobler; Luc Valiquette; Hans Heinzer; Patrizio Rigatti; Hartwig Huland; Pierre I Karakiewicz
Development and external validation of an extended repeat biopsy nomogram.
The Journal of urology 2007;177(2):510-5.
2007: Thomas Steuber; Andrew J Vickers; Angel M Serio; Ville Vaisanen; Alexander Haese; Kim Pettersson; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Clinical chemistry 2007;53(2):233-40.
2006: Thomas Steuber; Felix K-H Chun; Andreas Erbersdobler; Alberto Briganti; Alexander Haese; Markus Graefen; Thorsten Schlomm; Luc Valiquette; Hartwig Huland; Pierre I Karakiewicz
Development and internal validation of preoperative transition zone prostate cancer nomogram.
Urology 2006;68(6):1295-300.
2006: Felix K-H Chun; Alberto Briganti; Elie Antebi; Markus Graefen; Eike Currlin; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Alexander Haese; Martin G Friedrich; Sascha A Ahyai; Christian Eichelberg; Georg Salomon; Andrea Gallina; Andreas Erbersdobler; Paul Perrotte; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
BJU international 2006;98(6):1204-9.
2006: Jochen Walz; Markus Graefen; Felix K-H Chun; Andreas Erbersdobler; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Hartwig Huland; Pierre I Karakiewicz
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
European urology 2006;50(3):498-505.
2006: Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Markus Graefen; Francesco Montorsi; Andreas Erbersdobler; Thomas Steuber; Andrea Salonia; Eike Currlin; Vincenzo Scattoni; Martin G Friedrich; Thorsten Schlomm; Alexander Haese; Uwe Michl; Renzo Colombo; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Claus G Roehrborn; Hartwig Huland; Pierre I Karakiewicz
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
BJU international 2006;98(2):329-34.
2006: Felix K-H Chun; Markus Graefen; Mario Zacharias; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Pierre I Karakiewicz; Hartwig Huland
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
World journal of urology 2006;24(3):273-80.
2006: Christian Eichelberg; Andreas Erbersdobler; Alexander Haese; Thorsten Schlomm; Felix K-H Chun; Eike Currlin; Jochen Walz; Thomas Steuber; Markus Graefen; Hartwig Huland
Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.
European urology 2006;49(6):1011-6; discussion 1016-8.
2006: Timo Piironen; Alexander Haese; Hartwig Huland; Thomas Steuber; Ib Jarle Christensen; Nils Brünner; Keld Danø; Gunilla Høyer-Hansen; Hans Lilja
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Clinical chemistry 2006;52(5):838-44.
2006: Felix K-H Chun; Thomas Steuber; Andreas Erbersdobler; Eike Currlin; Jochen Walz; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Michael McCormack; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
European urology 2006;49(5):820-6.
2006: Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
The Journal of urology 2006;175(3 Pt 1):939-44; discussion 944.
2006: Thomas Steuber; Andrew J Vickers; Alexander Haese; Charlotte Becker; Kim Pettersson; Felix K-H Chun; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
2006: Thomas Steuber; Andreas Erbersdobler; Markus Graefen; Alexander Haese; Hartwig Huland; Pierre I Karakiewicz
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
Cancer 2006;106(4):775-82.
2006: Felix K-H Chun; Alberto Briganti; Thierry Lebeau; Vincent Fradet; Thomas Steuber; Jochen Walz; Thorsten Schlomm; Christian Eichelberg; Alexander Haese; Andreas Erbersdobler; Michael McCormack; Paul Perrotte; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
European urology 2006;49(2):273-8; discussion 278-9.
2005: Anoop M Meraney; Alexander Haese; Jüri Palisaar; Markus Graefen; Thomas Steuber; Hartwig Huland; Eric A Klein
Surgical management of prostate cancer: advances based on a rational approach to the data.
European journal of cancer (Oxford, England : 1990) 2005;41(6):888-907.
2005: Thomas Steuber; Pauliina Niemela; Alexander Haese; Kim Pettersson; Andreas Erbersdobler; K-H Felix Chun; Markus Graefen; Michael W Kattan; Hartwig Huland; Hans Lilja
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
The Prostate 2005;63(1):13-8.
2005: Thomas Steuber; Pierre I Karakiewicz; Herbert Augustin; Andreas Erbersdobler; Imke Lange; Alexander Haese; K-H F Chun; Jochen Walz; Markus Graefen; Hartwig Huland
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
The Journal of urology 2005;173(3):737-41.
2004: Alexander Haese; Joachim Noldus; Thomas Steuber; H Huland; Hans Lilja
[Isoforms of free prostate-specific antigen].
Der Urologe. Ausg. A 2004;43(6):675-9.
2004: Stefan H Hautmann; Martin G Friedrich; Salvador Fernandez; Thomas Steuber; Peter Hammerer; Peter M Braun; Klaus-Peter Jünemann; Hartwig Huland
Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal of small distal ureteral stones.
Urologia internationalis 2004;73(3):238-43.
2003: Alexander Haese; Markus Graefen; Thomas Steuber; Charlotte Becker; Joachim Noldus; Andreas Erbersdobler; Edith Huland; Hartwig Huland; Hans Lilja
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
The Journal of urology 2003;170(6 Pt 1):2269-73.
2002: Thomas Steuber; Paulina Nurmikko; Alexander Haese; Kim Pettersson; Markus Graefen; Peter Hammerer; Hartwig Huland; Hans Lilja
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
The Journal of urology 2002;168(5):1917-22.
2001: Alexander Haese; Markus Graefen; Thomas Steuber; Charlotte Becker; Kim Pettersson; Timo Piironen; Joachim Noldus; Hartwig Huland; Hans Lilja
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
The Prostate 2001;49(2):101-9.
2000: Peter Hammerer; Markus Graefen; Thomas Steuber; Hartwig Huland
[Chemoprevention of prostatic carcinoma].
Der Urologe. Ausg. A 2000;39(4):304-8.